GO:0014883 transition between fast and slow fiber: Fiber-Type Plasticity, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0014883 describes the conversion of fast-contracting muscle fibers toward a slower character, including slowed contractile rate, slow myosin gene induction, increased oxidative metabolism, altered electrophysiology and altered innervation.
• Myosin heavy chain (Myh) isoform switching is the molecular hallmark of fiber-type transitions, with Myh7 (slow/type I) induction and Myh2/Myh4 (fast/type II) repression.
• Exercise training, especially endurance training, is a major physiological driver of fast-to-slow transitions, although the magnitude and direction of shifts depend on training mode and species.
• Motor neuron activity and innervation patterns regulate fiber-type identity, and reinnervation can promote a slower, more oxidative phenotype.
• Aging and sarcopenia are associated with altered fiber-type composition and contractile protein remodeling, making GO:0014883 relevant to muscle wasting research.
• CRISPR-based knockout, knock-in, point-mutation and overexpression models enable causal testing of candidate regulators of fast-to-slow fiber transitions.
Description
Skeletal muscle is a highly plastic tissue that can adjust its contractile and metabolic properties in response to exercise, innervation, aging and disease. The Gene Ontology term GO:0014883, transition between fast and slow fiber, captures the biological process by which fast-contracting muscle fibers acquire a slower character, including reduced contractile speed, induction of slow myosin isoforms, increased oxidative capacity, altered electrophysiology and altered innervation. This process is central to understanding how muscles adapt to endurance training, disuse, reinnervation and metabolic stress. At the molecular level, fiber-type transitions are defined by coordinated changes in myosin heavy chain (Myh) gene expression, with slow-type Myh7 induction and fast-type Myh2/Myh4 repression being widely used as markers. These changes are accompanied by shifts in mitochondrial content, oxidative enzymes and calcium-handling proteins that together determine fatigue resistance and metabolic efficiency. Because fiber-type composition influences whole-body metabolism, mobility and disease susceptibility, researchers study GO:0014883 to identify causal regulators and therapeutic targets. This article integrates the QuickGO definition of GO:0014883 with verified PubMed literature to summarize the mechanism, key genes, disease relevance and experimental methods, including CRISPR-based models for functional validation.
transition between fast and slow fiber At A Glance
| GO ID | GO:0014883 |
|---|---|
| GO term | transition between fast and slow fiber |
| Ontology | biological_process |
| Synonym | transition between fast and slow fibre; transition fast-slow fiber; transition fast-slow fibre |
| Major function | Conversion of fast-contracting muscle fibers to a slower, more oxidative character |
| Key molecular markers | Myh7 induction; Myh2/Myh4 repression; oxidative enzyme changes |
| Physiological triggers | Endurance exercise, altered innervation, reinnervation, metabolic and aging-related signals |
| Research relevance | Muscle plasticity, sarcopenia, metabolic disease, neuromuscular disorders, exercise physiology |
What Is GO:0014883?
GO:0014883 (transition between fast and slow fiber) is the biological process of converting fast-contracting muscle fibers to a slower character. According to the QuickGO definition, this may involve slowing of contractile rate, slow myosin gene induction, an increase in oxidative metabolic properties, altered electrophysiology and altered innervation. The process also regulates skeletal muscle adaptation. In practice, researchers operationalize this term by measuring changes in myosin heavy chain isoform expression, contractile kinetics, mitochondrial and oxidative enzyme content, and innervation status.
Why Is transition between fast and slow fiber Important in Cell Biology?
GO:0014883 is important because fiber-type composition determines contractile speed, fatigue resistance and metabolic fuel use, and its dysregulation is linked to aging, sarcopenia, metabolic disease and neuromuscular disorders. Understanding the transition between fast and slow fibers helps explain how exercise training improves endurance, how denervation and reinnervation reshape muscle, and how systemic signals such as gut microbiota-derived metabolites influence muscle phenotype. It also provides a framework for identifying therapeutic targets to preserve or restore muscle function in disease.
• Defines the molecular and physiological basis of muscle fiber plasticity.
• Explains endurance-training adaptations, including increased oxidative capacity and fatigue resistance.
• Links innervation and motor neuron activity to fiber-type identity.
• Provides markers (Myh7, Myh2, Myh4) for assessing muscle phenotype in models and humans.
• Relevant to sarcopenia and age-related muscle weakness.
• Relevant to metabolic disease and diabetes-induced muscle atrophy.
• Relevant to neuromuscular disorders and reinnervation strategies.
• Supports discovery of systemic regulators such as microbiota-derived metabolites.
• Enables CRISPR-based causal testing of candidate regulators.
• Informs exercise mimetics and therapeutic strategies for muscle wasting.
What Happens During transition between fast and slow fiber?
Initiation by altered activity and innervation
In simple terms: The process often starts when a fast fiber receives a more slow-like pattern of nerve activity.
Fiber-type transitions are initiated by changes in motor neuron activity and innervation patterns, which alter the transcriptional program of the muscle fiber. Type-selective ablation of motor neurons in mice can induce fiber-type transition and late-onset tremor, demonstrating that innervation is a key upstream regulator of GO:0014883. Reinnervation in elderly people is also associated with changes in muscle fiber phenotype, supporting the role of neural input in fast-to-slow conversion.
Myosin heavy chain isoform switching
In simple terms: The fiber changes which myosin protein it makes, swapping fast myosin for slow myosin.
A central event in GO:0014883 is the induction of slow myosin genes such as Myh7 and the repression of fast myosin genes such as Myh2 and Myh4. Myosin isoforms are major determinants of contractile speed and ATPase activity, so their switching directly changes fiber physiology. Gut microbiota-mediated betaine regulates skeletal muscle fiber type transition by affecting m6A RNA methylation and Myh7 expression, illustrating that Myh7 induction is a convergent node for diverse regulatory inputs.
Metabolic remodeling toward oxidative phenotype
In simple terms: The fiber becomes better at using oxygen and resisting fatigue.
Fast-to-slow transitions typically involve an increase in oxidative metabolic properties, including mitochondrial content and oxidative enzyme activity. Proteomic profiling of the contractile apparatus in aging muscle shows remodeling of contractile and metabolic proteins consistent with fiber-type shifting in sarcopenia. Exercise training is a classic stimulus for these oxidative adaptations, although the direction and magnitude of fiber-type shifts depend on training mode and species.
Electrophysiological and contractile changes
In simple terms: The fiber contracts more slowly and its electrical behavior changes.
Slowing of contractile rate and altered electrophysiology are defining features of GO:0014883. These changes are driven by myosin isoform switching and by alterations in calcium handling and membrane properties. Human studies describe the transition between fast and slow fibre types as a measurable physiological process, supporting its use as an experimental endpoint.
Systemic and disease-associated regulation
In simple terms: Signals from the whole body, including gut microbes and metabolic stress, can push fibers toward a slower type.
Systemic signals can regulate GO:0014883. Gut microbiota-mediated betaine affects m6A RNA methylation and Myh7 expression, linking the microbiome to fiber-type transition. Diabetes-induced muscle atrophy involves SIRT1/FoxO1/3a-mediated mitochondrial function, and aptamer-conjugated exosomes can ameliorate this atrophy, indicating that metabolic disease pathways intersect with fiber-type regulation. Aging and sarcopenia are also associated with fiber-type shifting and contractile apparatus remodeling.
Key Genes Involved in GO:0014883 transition between fast and slow fiber
The following genes and proteins are central to the regulation and readout of GO:0014883, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYH7 | Slow/type I myosin heavy chain; marker of slow fiber identity | Induction marks fast-to-slow transition; regulated by m6A methylation |
| MYH2 | Fast/type IIa myosin heavy chain | Repression accompanies slow fiber conversion |
| MYH4 | Fast/type IIb myosin heavy chain | Repression accompanies slow fiber conversion |
| MYH1 | Fast/type IIx myosin heavy chain | Isoform switching readout in fiber-type studies |
| SIRT1 | NAD+-dependent deacetylase; mitochondrial regulator | Involved in diabetes-induced muscle atrophy and mitochondrial function |
| FOXO1 | Transcription factor downstream of SIRT1 | Mediates mitochondrial and atrophy-related gene programs |
| FOXO3A | Transcription factor downstream of SIRT1 | Mediates mitochondrial and atrophy-related gene programs |
| METTL3 | m6A RNA methyltransferase component | m6A methylation regulates Myh7 expression in fiber-type transition |
| METTL14 | m6A RNA methyltransferase component | m6A methylation regulates Myh7 expression in fiber-type transition |
| FTO | m6A RNA demethylase | Potential modulator of m6A-dependent Myh7 regulation |
| ALKBH5 | m6A RNA demethylase | Potential modulator of m6A-dependent Myh7 regulation |
| AMPK | Energy sensor kinase | Links metabolic stress to oxidative fiber phenotype |
| PGC-1alpha (PPARGC1A) | Mitochondrial biogenesis coactivator | Promotes oxidative, slow-like phenotype |
| MYOD1 | Myogenic regulatory factor | Muscle fiber gene regulation |
| MYOG | Myogenic regulatory factor | Muscle fiber gene regulation |
| MEF2C | Transcription factor | Regulates slow fiber gene programs |
| NFAT | Calcium-responsive transcription factor | Links nerve activity to slow fiber genes |
How Is transition between fast and slow fiber Regulated?
GO:0014883 is regulated by neural activity, exercise, metabolic signals and epigenetic mechanisms. Altered innervation and motor neuron activity change the transcriptional program of muscle fibers, as shown by type-selective motor neuron ablation inducing fiber-type transition. Endurance exercise training is a physiological regulator of fast-to-slow transitions, although the response depends on training mode and species. Epigenetic regulation via m6A RNA methylation controls Myh7 expression and fiber-type transition in response to gut microbiota-derived betaine. Metabolic and mitochondrial regulators such as SIRT1/FoxO1/3a are implicated in diabetes-induced muscle atrophy and mitochondrial function, which intersect with fiber-type regulation. Aging-related changes in the contractile apparatus also modulate fiber-type composition.
transition between fast and slow fiber and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MYH7 | Fiber-type transition marker; m6A-regulated | Knock-in reporter of Myh7; m6A perturbation |
| SIRT1 | Diabetes-induced muscle atrophy; mitochondrial dysfunction | Knockout or overexpression in muscle cells |
| FOXO1 | Atrophy and mitochondrial gene regulation | Point mutation of phosphorylation sites |
| FOXO3A | Atrophy and mitochondrial gene regulation | Knockout or point mutation |
| Motor neuron genes | Tremor and myopathy after fiber-type transition | Type-selective motor neuron ablation mouse models |
Sarcopenia and aging
Aging is associated with fiber-type shifting and remodeling of the contractile apparatus, contributing to sarcopenia and reduced muscle function. Proteomic profiling of the contractile apparatus in old skeletal muscle reveals changes consistent with altered fiber-type composition. Reinnervation of skeletal muscle in elderly people is also linked to fiber-type changes, suggesting that age-related denervation-reinnervation cycles influence GO:0014883.
Metabolic disease and diabetes-induced muscle atrophy
Diabetes-induced muscle atrophy involves impaired mitochondrial function mediated by SIRT1/FoxO1/3a, and aptamer-conjugated exosomes can ameliorate this atrophy. Because fiber-type transitions are tied to oxidative metabolism, metabolic disease pathways intersect with GO:0014883. Gut microbiota-mediated betaine regulates fiber-type transition via m6A RNA methylation and Myh7 expression, further linking systemic metabolism to muscle phenotype.
Neuromuscular disorders and tremor
Type-selective ablation of postnatal slow and fast fatigue-resistant motor neurons in mice induces late-onset kinetic and postural tremor following fiber-type transition and myopathy. This demonstrates that disruption of innervation can drive fiber-type transition and motor dysfunction. Reinnervation strategies in elderly people also highlight the clinical relevance of nerve-muscle interactions in GO:0014883.
From transition between fast and slow fiber-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is Myh7 induction required for fast-to-slow transition? | Myh7 knockout or knock-in reporter in muscle cells |
| Does m6A methylation regulate Myh7 and fiber type? | METTL3/METTL14 knockout or FTO/ALKBH5 overexpression |
| Does SIRT1/FoxO1/3a mediate diabetes-induced atrophy? | SIRT1 knockout, FoxO1/3a point mutants |
| Does innervation drive fiber-type transition? | Motor neuron type-selective ablation mouse models |
| Can exercise mimic a slow fiber program? | Endurance training models with fiber-type readouts |
| Does gut microbiota-derived betaine affect fiber type? | Microbiota manipulation plus Myh7 expression assays |
How to Study the transition between fast and slow fiber Process
| Method | What It Measures | Typical Application |
|---|---|---|
| qPCR | Myh isoform mRNA levels | Fast-to-slow transition marker analysis |
| RNA-seq | Global transcriptome changes | Discovery of fiber-type regulators |
| m6A RNA methylation assays | Epitranscriptomic marks on Myh7 | Linking m6A to fiber-type transition |
| Western blot | Myosin protein isoform expression | Confirmation of fiber-type switching |
| Immunofluorescence | Fiber-type composition in tissue sections | Histological assessment of transition |
| Proteomics | Contractile apparatus protein remodeling | Aging and sarcopenia studies |
| Contractile physiology | Contractile rate and fatigue resistance | Functional confirmation of slow phenotype |
| Motor neuron ablation models | Innervation-dependent fiber-type changes | Neuromuscular disease research |
Myosin heavy chain isoform profiling
Fiber-type transitions are commonly assessed by measuring Myh isoform expression at the mRNA and protein levels, using qPCR, RNA-seq, western blot or immunofluorescence. Myh7 induction and Myh2/Myh4 repression are standard readouts of GO:0014883.
Transcriptomic and epitranscriptomic analysis
RNA-seq and m6A RNA methylation assays can identify global changes in gene expression and epitranscriptomic marks associated with fiber-type transition. These approaches are useful for discovering regulators such as METTL3/METTL14 and for linking systemic signals to Myh7 expression.
Proteomics of the contractile apparatus
Proteomic profiling of the contractile apparatus can quantify changes in myosin isoforms and other structural proteins during aging and fiber-type shifting. This method provides a direct biochemical readout of fiber-type composition.
Physiological and contractile measurements
Contractile rate, fatigue resistance and electrophysiological properties can be measured in isolated muscle preparations or in vivo to confirm functional fast-to-slow conversion. Human studies describe the transition between fast and slow fibre types using physiological endpoints.
How CRISPR Can Be Used to Study GO:0014883 transition between fast and slow fiber
Knockout
CRISPR knockout of candidate regulators such as SIRT1, FOXO1, FOXO3A, METTL3 or METTL14 can test whether they are required for fast-to-slow fiber transitions. Knockout models enable causal inference beyond correlative expression data.
Point Mutation
Point mutations can be introduced into phosphorylation or catalytic sites of regulators such as FOXO1/3a to dissect signaling mechanisms in fiber-type transition. This approach is useful when complete knockout is lethal or confounded by developmental effects.
Knock-in
Knock-in of reporters or tags at the Myh7 locus allows real-time monitoring of slow myosin induction during fiber-type transition. Tagged knock-in of m6A machinery components can also enable epitranscriptomic studies.
Overexpression
Overexpression of slow-fiber-promoting genes such as PPARGC1A or constitutively active FOXO mutants can drive a slow, oxidative phenotype in muscle cells. Overexpression models are useful for gain-of-function studies of GO:0014883 regulators.
How EDITGENE Supports transition between fast and slow fiber Research
Researchers studying transition between fast and slow fiber-related genes often need to determine whether a candidate gene is causally involved in fiber-type switching or merely correlated with it. CRISPR-based models provide the necessary gain-of-function and loss-of-function evidence to move from association to mechanism.
Contact EDITGENE today to design your custom CRISPR model for transition between fast and slow fiber research.
Frequently Asked Questions About transition between fast and slow fiber
What is GO:0014883 transition between fast and slow fiber?
GO:0014883 is the biological process of converting fast-contracting muscle fibers to a slower character, involving slowed contractile rate, slow myosin gene induction, increased oxidative metabolism, altered electrophysiology and altered innervation.
What genes are involved in transition between fast and slow fiber?
Key genes include MYH7 (slow myosin), MYH2 and MYH4 (fast myosins), SIRT1, FOXO1, FOXO3A, METTL3, METTL14 and PPARGC1A.
How is fast-to-slow fiber transition measured?
It is measured by Myh isoform expression, oxidative enzyme activity, mitochondrial content, contractile rate and electrophysiology.
Does exercise cause fast-to-slow fiber transition?
Endurance exercise training is a major physiological driver of fast-to-slow transitions, although the response depends on training mode and species.
What is the role of Myh7 in slow fiber transition?
Myh7 encodes slow/type I myosin heavy chain, and its induction is a hallmark of fast-to-slow fiber transition.
How does m6A methylation regulate fiber type?
m6A RNA methylation regulates Myh7 expression, and gut microbiota-mediated betaine affects fiber-type transition via m6A and Myh7.
Is fiber-type transition relevant to sarcopenia?
Yes, aging and sarcopenia are associated with fiber-type shifting and contractile apparatus remodeling.
Can CRISPR be used to study fiber-type transition?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models can test causal roles of candidate regulators.
What is the role of innervation in fiber-type transition?
Motor neuron activity and innervation regulate fiber-type identity, and type-selective motor neuron ablation induces fiber-type transition and tremor in mice.
Which diseases involve altered fast-to-slow fiber transition?
Sarcopenia, diabetes-induced muscle atrophy, neuromuscular disorders and tremor-related myopathy are associated with altered fiber-type transition.
Conclusion
GO:0014883 transition between fast and slow fiber is a central biological process in skeletal muscle plasticity, defined by myosin isoform switching, oxidative metabolic remodeling and altered contractile physiology. It is regulated by neural activity, exercise, epigenetic mechanisms and systemic metabolic signals, and it is relevant to aging, sarcopenia, metabolic disease and neuromuscular disorders. CRISPR-based knockout, point-mutation, knock-in and overexpression models provide powerful tools to move from correlation to causal mechanism in this field.
References
- 1. Plotkin DL et al.. 2021. Muscle Fiber Type Transitions with Exercise Training: Shifting Perspectives.. Sports (Basel) 9(9) PMID: 34564332
- 2. Pette D et al.. 2000. Myosin isoforms, muscle fiber types, and transitions.. Microsc Res Tech 50(6):500-9 PMID: 10998639
- 3. Yan C et al.. 2025. Gut microbiota-mediated betaine regulates skeletal muscle fiber type transition by affecting m(6)A RNA methylation and Myh7 expression.. Gut Microbes 17(1):2545434 PMID: 40824213
- 4. Coletti C et al.. 2022. Exercise-mediated reinnervation of skeletal muscle in elderly people: An update.. Eur J Transl Myol 32(1) PMID: 35234025
- 5. Dowling P et al.. 2023. Fiber-Type Shifting in Sarcopenia of Old Age: Proteomic Profiling of the Contractile Apparatus of Skeletal Muscles.. Int J Mol Sci 24(3) PMID: 36768735
- 6. Neunhäuserer D et al.. 2011. Human skeletal muscle: transition between fast and slow fibre types.. Pflugers Arch 461(5):537-43 PMID: 21360037
- 7. Song J et al.. 2025. Aptamer-Conjugated Exosomes Ameliorate Diabetes-Induced Muscle Atrophy by Enhancing SIRT1/FoxO1/3a-Mediated Mitochondrial Function.. J Cachexia Sarcopenia Muscle 16(1):e13717 PMID: 39871746
- 8. Misawa H et al.. 2024. Type selective ablation of postnatal slow and fast fatigue-resistant motor neurons in mice induces late onset kinetic and postural tremor following fiber-type transition and myopathy.. Exp Neurol 376:114772 PMID: 38599366
